• Search
  • Helpdesk
  • Sales contact

Rare Disease case study

30 March 2023

Over 90% of rare diseases have no treatment… 

  • There are more than 6,000 known rare diseases…
  • Approximately 80% of them have a genetic component… 75% affect children…
  • And most rare diseases are chronic conditions, many of which progress overtime and are potentially fatal…

Understanding the rare disease framework is key to be able to offer study participants adapted solutions and as such, positively contribute to important and necessary clinical research conducted on rare diseases.

Kayentis offers an extensive experience in rare disease clinical trials, in indications such as:

  • Prader-Willi Syndrome
  • PIK3CA-related overgrowth spectrum
  • Auto-Immune Hepatitis (AIH)
  • Hypoparathyroidism
  • Sjögren’s syndrome
  • Acute Vertigo

Download the case study 👇
Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

C-PATH 2025

APR 9-10 2025 • Rockville, Maryland, USA

OCT Europe 2025

APR 29-30 2025 • Barcelona, Spain
Booth #74 15th Annual Outsourcing in Clinical Trials Europe 2025 - Arena International

OCT East Coast 2025

MAY 20-21 2025 • King of Prussia, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

PCMG 2025

JUNE 10-12 2025 • Malaga, Spain
PCMG Annual Assembly 2025